BBIO
BridgeBio Pharma, Inc.
- Latest sale
- $4.3M
- Nov 19 · Routine
- Form 4 sales
- 177
- On record
- Form 144 notices
- 14
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineJul 9 2026
Sold 148,589 shares at $88.54 ($13.2M)
Cook Jennifer E., Director
10b5-1 planSold 94.7% of holdings ($13.9M position)8,383 shares leftFiling
- 2 Form 4 saleRoutineJul 9 same day
Sold 17,167 shares at $84.00 ($1.4M)
Ellis Andrea, Director
10b5-1 planSold 43.2% of holdings ($3.3M position)22,579 shares left0.7x usual sizeFiling
- 3 Form 4 saleRoutineJul 30 +21 days
Sold 2,000 shares at $80.06 ($160k)
Apuli Maricel, Chief Accounting Officer
10b5-1 planSold 1.5% of holdings ($10.4M position)127,401 shares left1.3x usual sizeFiling
- 4 Form 4 saleRoutineAug 19 +20 days
Sold 44,980 shares at $82.86 ($3.7M)
Kumar Neil, Chief Executive Officer
10b5-1 planSold 15.6% of holdings ($23.9M position)243,327 shares left0.6x usual sizeFiling
- 5 Form 4 saleRoutineSep 17 +29 days
Sold 10,000 shares at $69.08 ($691k)
Kumar Neil, Chief Executive Officer
10b5-1 planSold 2% of holdings ($34.9M position)495,686 shares left0.1x usual sizeFiling
- 6 Form 144 noticeNoticeNov 18 +62 days
Filed to sell 34,980 shares ($2.7M)
Kumar Neil, Director, Officer
10b5-1 plan0.4x usual sizeFiling
- 7 Form 144 noticeNoticeNov 19 +1 day
Filed to sell 30,000 shares ($2.3M)
Kumar Neil, Director, Officer
10b5-1 plan0.4x usual sizeFiling
- 8 Form 4 saleRoutineNov 19 same day
Sold 54,980 shares at $77.86 ($4.3M)
Kumar Neil, Chief Executive Officer
10b5-1 planSold 18.4% of holdings ($23.2M position)243,327 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (191)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 54,980 | $4.3M | 18.4% | Routine | SEC |
| Nov 19, 2026 | Kumar Neil | Director, Officer | Form 144 notice | 30,000 | $2.3M | Notice | SEC | |
| Nov 18, 2026 | Kumar Neil | Director, Officer | Form 144 notice | 34,980 | $2.7M | Notice | SEC | |
| Sep 17, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 10,000 | $691k | 2.0% | Routine | SEC |
| Aug 19, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 44,980 | $3.7M | 15.6% | Routine | SEC |
| Jul 30, 2026 | Apuli Maricel | Chief Accounting Officer | Form 4 sale | 2,000 | $160k | 1.5% | Routine | SEC |
| Jul 9, 2026 | Ellis Andrea | Director | Form 4 sale | 17,167 | $1.4M | 43.2% | Routine | SEC |
| Jul 9, 2026 | Cook Jennifer E. | Director | Form 4 sale | 148,589 | $13.2M | 94.7% | Routine | SEC |
| Jun 24, 2026 | Cook Jennifer E. | Director | Form 4 sale | 39,363 | $2.8M | 82.4% | Routine | SEC |
| Jun 23, 2026 | Valantine Hannah | Director | Form 4 sale | 5,004 | $342k | 35.1% | Routine | SEC |
| Jun 15, 2026 | Cook Jennifer E. | Director | Form 4 sale | 90,240 | $6M | 93.2% | Routine | SEC |
| Jun 5, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $5.4M | 1.8% | Routine | SEC |
| May 21, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 26,103 | $1.8M | 9.7% | Routine | SEC |
| May 18, 2026 | Trimarchi Thomas | President and CFO | Form 4 sale | 13,651 | $888k | 3.7% | Routine | SEC |
| May 15, 2026 | Scott Randal W. | Director | Form 4 sale | 10,000 | $671k | 46.3% | Routine | SEC |
| May 8, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $5.4M | 1.8% | Routine | SEC |
| Apr 30, 2026 | Apuli Maricel | Chief Accounting Officer | Form 4 sale | 2,000 | $143k | 1.5% | Routine | SEC |
| Apr 10, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $6M | 1.8% | Routine | SEC |
| Mar 13, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $5.5M | 1.8% | Routine | SEC |
| Mar 10, 2026 | Valantine Hannah | Director | Form 4 sale | 8,671 | $624k | 53.7% | Routine | SEC |
| Mar 4, 2026 | Ellis Andrea | Director | Form 4 sale | 64,921 | $4.2M | 77.7% | Unusual | SEC |
| Feb 27, 2026 | Valantine Hannah | Director | Form 4 sale | 25,484 | $1.7M | 77.3% | Routine | SEC |
| Feb 26, 2026 | Apuli Maricel | Chief Accounting Officer | Form 4 sale | 2,000 | $132k | 1.6% | Routine | SEC |
| Feb 19, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 28,053 | $2M | 10.7% | Routine | SEC |
| Feb 17, 2026 | Apuli Maricel | Chief Accounting Officer | Form 4 sale | 510 | $38k | 0.4% | Routine | SEC |
| Feb 17, 2026 | Trimarchi Thomas | President and CFO | Form 4 sale | 13,600 | $1M | 3.9% | Routine | SEC |
| Feb 17, 2026 | Scott Randal W. | Director | Form 4 sale | 10,000 | $755k | 46.3% | Unusual | SEC |
| Feb 11, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $5.7M | 1.8% | Routine | SEC |
| Jan 9, 2026 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $6M | 1.7% | Routine | SEC |
| Dec 15, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 30,011 | $2.2M | 11.6% | Routine | SEC |
| Dec 8, 2025 | Apuli Maricel | Chief Accounting Officer | Form 4 sale | 2,000 | $149k | 1.5% | Routine | SEC |
| Dec 5, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $5.9M | 1.7% | Routine | SEC |
| Nov 20, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 26,156 | $1.7M | 10.3% | Routine | SEC |
| Nov 18, 2025 | Lo Andrew | Director | Form 4 sale | 95,599 | $6.3M | 87.2% | Unusual | SEC |
| Nov 17, 2025 | Scott Randal W. | Director | Form 4 sale | 10,000 | $666k | 46.3% | Unusual | SEC |
| Nov 17, 2025 | Trimarchi Thomas | President and CFO | Form 4 sale | 16,934 | $1.1M | 4.2% | Routine | SEC |
| Nov 12, 2025 | Valantine Hannah | Director | Form 4 sale | 25,484 | $1.7M | 77.3% | Unusual | SEC |
| Nov 7, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $5M | 9.1% | Routine | SEC |
| Nov 6, 2025 | Daniels Ronald J | Director | Form 4 sale | 61,031 | $3.9M | 78.2% | Unusual | SEC |
| Oct 29, 2025 | Mccormick Frank | Director | Form 4 sale | 198,359 | $13.2M | 22.6% | Routine | SEC |
| Oct 27, 2025 | Mccormick Frank | Director | Form 4 sale | 1,641 | $107k | 0.2% | Routine | SEC |
| Oct 9, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $4.4M | 8.7% | Routine | SEC |
| Sep 5, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $4.2M | 8.4% | Routine | SEC |
| Sep 5, 2025 | Mccormick Frank | Director | Form 4 sale | 74,000 | $3.9M | 47.1% | Unusual | SEC |
| Aug 21, 2025 | Trimarchi Thomas | President and CFO | Form 4 sale | 42,237 | $2.1M | 9.1% | No plan | SEC |
| Aug 20, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 26,156 | $1.3M | 10.5% | Routine | SEC |
| Aug 18, 2025 | Trimarchi Thomas | President and CFO | Form 4 sale | 17,353 | $872k | 3.6% | Routine | SEC |
| Aug 11, 2025 | Homcy Charles J | Director | Form 4 sale | 300,000 | $13.9M | 24.7% | Routine | SEC |
| Aug 8, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $3.7M | 8.0% | Routine | SEC |
| Aug 7, 2025 | Apuli Maricel | Chief Accounting Officer | Form 4 sale | 1,000 | $45k | 0.7% | No plan | SEC |
| Aug 5, 2025 | Ellis Andrea | Director | Form 4 sale | 17,167 | $841k | 48.0% | Routine | SEC |
| Jul 2, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 80,000 | $3.4M | 7.7% | Routine | SEC |
| Jun 27, 2025 | Halvorsen Ole Andreas | 10% owner | Form 4 sale | 3.5M | $154M | 15.9% | No plan | SEC |
| Jun 26, 2025 | Valantine Hannah | Director | Form 4 sale | 4,707 | $207k | 38.7% | Unusual | SEC |
| Jun 24, 2025 | Mccormick Frank | Director | Form 4 sale | 100,000 | $4.4M | 10.2% | Routine | SEC |
| Jun 10, 2025 | Valantine Hannah | Director | Form 4 sale | 4,292 | $172k | 70.9% | Routine | SEC |
| May 20, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 101,156 | $3.4M | 31.8% | Routine | SEC |
| May 12, 2025 | Kravis Henry R | 10% owner | Form 4 sale | 6M | $205M | 31.2% | Unusual | SEC |
| May 2, 2025 | Apuli Maricel | Chief Accounting Officer | Form 4 sale | 1,026 | $40k | 0.7% | No plan | SEC |
| May 2, 2025 | Lo Andrew | Director | Form 4 sale | 100,000 | $3.9M | 48.6% | Unusual | SEC |
| Apr 22, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 75,000 | $2.6M | 1.5% | Routine | SEC |
| Apr 14, 2025 | Ellis Andrea | Director | Form 4 sale | 10,000 | $350k | 45.5% | Routine | SEC |
| Apr 1, 2025 | Ellis Andrea | Director | Form 4 sale | 30,000 | $1M | 71.4% | Routine | SEC |
| Mar 25, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 75,000 | $2.8M | 1.5% | Routine | SEC |
| Mar 6, 2025 | Valantine Hannah | Director | Form 4 sale | 12,875 | $419k | 87.9% | Unusual | SEC |
| Mar 5, 2025 | KKR Group Holdings Corp. | 10% owner | Form 4 sale | 6M | $198M | 23.8% | No plan | SEC |
| Feb 25, 2025 | Stephenson Brian C | CFO and Treasurer | Form 4 sale | 8,500 | $282k | 7.7% | Routine | SEC |
| Feb 25, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 75,000 | $2.5M | 1.5% | Routine | SEC |
| Feb 19, 2025 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 4,148 | $150k | 3.9% | Routine | SEC |
| Feb 19, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 31,543 | $1.1M | 13.0% | Routine | SEC |
| Jan 31, 2025 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% owner | Form 4 sale | 3.1M | $107M | 12.2% | No plan | SEC |
| Jan 29, 2025 | Kumar Neil | Chief Executive Officer | Form 4 sale | 600,000 | $21.8M | 10.5% | Unusual | SEC |
| Jan 28, 2025 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 68,000 | $2.5M | 42.0% | Routine | SEC |
| Nov 19, 2024 | Kumar Neil | Chief Executive Officer | Form 4 sale | 27,389 | $614k | 0.6% | Routine | SEC |
| Nov 19, 2024 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 4,156 | $93k | 4.2% | Routine | SEC |
| Sep 13, 2024 | KKR & Co. Inc. | 10% owner | Form 4 sale | 5.8M | $149M | 18.7% | No plan | SEC |
| Aug 19, 2024 | Kumar Neil | Chief Executive Officer | Form 4 sale | 27,389 | $676k | 0.6% | Routine | SEC |
| Aug 19, 2024 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 4,155 | $103k | 4.7% | Routine | SEC |
| Jun 4, 2024 | Scott Randal W. | Director | Form 4 sale | 2,500 | $76k | 38.5% | Routine | SEC |
| Mar 1, 2024 | Scott Randal W. | Director | Form 4 sale | 2,500 | $85k | 27.8% | Routine | SEC |
| Feb 15, 2024 | Valantine Hannah | Director | Form 4 sale | 2,915 | $110k | 62.3% | Routine | SEC |
| Jan 16, 2024 | Valantine Hannah | Director | Form 4 sale | 2,915 | $111k | 62.3% | Routine | SEC |
| Dec 26, 2023 | Mccormick Frank | Director | Form 4 sale | 100,000 | $4.2M | 13.7% | Routine | SEC |
| Dec 18, 2023 | Scott Randal W. | Director | Form 4 sale | 2,000 | $80k | 18.2% | Routine | SEC |
| Dec 15, 2023 | Valantine Hannah | Director | Form 4 sale | 2,915 | $105k | 62.3% | Routine | SEC |
| Dec 1, 2023 | Scott Randal W. | Director | Form 4 sale | 2,500 | $74k | 18.5% | Routine | SEC |
| Dec 1, 2023 | Scott Randal W. | Director | Form 144 notice | 1,500 | $43k | Notice | SEC | |
| Nov 17, 2023 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 22,685 | $660k | 38.2% | Routine | SEC |
| Nov 17, 2023 | Kumar Neil | CEO and President | Form 4 sale | 51,552 | $1.5M | 1.1% | Routine | SEC |
| Nov 17, 2023 | Stephenson Brian C | Officer | Form 144 notice | 22,685 | $655k | Notice | SEC | |
| Nov 17, 2023 | Kumar Neil | Officer | Form 144 notice | 51,552 | $1.5M | Notice | SEC | |
| Nov 15, 2023 | Valantine Hannah | Director | Form 4 sale | 2,915 | $87k | 62.3% | Routine | SEC |
| Nov 15, 2023 | Valantine Hannah | Director | Form 144 notice | 2,915 | $87k | Notice | SEC | |
| Sep 5, 2023 | Scott Randal W. | Director | Form 4 sale | 2,500 | $75k | 15.6% | Routine | SEC |
| Sep 5, 2023 | Scott Randal W. | Director | Form 144 notice | 3,500 | $107k | Notice | SEC | |
| Aug 17, 2023 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 22,683 | $649k | 38.2% | Routine | SEC |
| Aug 17, 2023 | Kumar Neil | CEO and President | Form 4 sale | 51,552 | $1.5M | 1.1% | Routine | SEC |
| Aug 17, 2023 | Kumar Neil | Director, Officer | Form 144 notice | 51,552 | $1.5M | Notice | SEC | |
| Aug 17, 2023 | Stephenson Brian C | Officer | Form 144 notice | 22,683 | $676k | Notice | SEC | |
| Jul 18, 2023 | Viking Global Opportunities GP LLC | 10% owner | Form 4 sale | 1.5M | $52.5M | 5.6% | No plan | SEC |
| Jul 18, 2023 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% Stockholder | Form 144 notice | 1.5M | $48.1M | Notice | SEC | |
| May 17, 2023 | Kumar Neil | CEO and President | Form 4 sale | 51,552 | $722k | 1.1% | Routine | SEC |
| May 17, 2023 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 24,424 | $342k | 40.1% | Routine | SEC |
| May 17, 2023 | Kumar Neil | Officer | Form 144 notice | 51,552 | $726k | Notice | SEC | |
| May 17, 2023 | Stephenson Brian C | Officer | Form 144 notice | 24,424 | $344k | Notice | SEC | |
| May 3, 2023 | Kumar Neil | CEO and President | Form 4 sale | 120,000 | $1.7M | 10.6% | Routine | SEC |
| May 3, 2023 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 64,929 | $921k | 64.1% | Routine | SEC |
| May 3, 2023 | Kumar Neil | Officer | Form 144 notice | 120,000 | $1.7M | Notice | SEC | |
| Apr 5, 2023 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 55,500 | $857k | 35.4% | Routine | SEC |
| Apr 5, 2023 | Kumar Neil | CEO and President | Form 4 sale | 120,000 | $1.9M | 9.6% | Routine | SEC |
| Apr 5, 2023 | Kumar Neil | Officer | Form 144 notice | 120,000 | $1.9M | Notice | SEC | |
| Mar 3, 2023 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 62,692 | $687k | 28.6% | Unusual | SEC |
| Mar 3, 2023 | Kumar Neil | CEO and President | Form 4 sale | 120,000 | $1.3M | 8.7% | Plan not stated | SEC |
| Feb 17, 2023 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 17,717 | $225k | 7.5% | Plan not stated | SEC |
| Feb 17, 2023 | Kumar Neil | CEO and President | Form 4 sale | 44,798 | $569k | 0.9% | Plan not stated | SEC |
| Feb 3, 2023 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 61,040 | $672k | 21.8% | Plan not stated | SEC |
| Feb 3, 2023 | Kumar Neil | CEO and President | Form 4 sale | 120,000 | $1.3M | 8.0% | Plan not stated | SEC |
| Jan 5, 2023 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 61,040 | $468k | 17.9% | Plan not stated | SEC |
| Jan 5, 2023 | Kumar Neil | CEO and President | Form 4 sale | 120,000 | $920k | 7.4% | Plan not stated | SEC |
| Dec 21, 2022 | Kumar Neil | CEO and President | Form 4 sale | 200,000 | 16.7% | Plan not stated | SEC | |
| Nov 17, 2022 | Kumar Neil | CEO and President | Form 4 sale | 34,640 | $326k | 0.7% | Plan not stated | SEC |
| Nov 17, 2022 | Stephenson Brian C | Secretary, Treasurer & CFO | Form 4 sale | 19,678 | $185k | 5.5% | Plan not stated | SEC |
| Dec 28, 2021 | Daniels Ronald J | Director | Form 4 sale | 11,745 | $150k | 100.0% | Unusual | SEC |
| Aug 4, 2021 | Scheller Richard H | Officer, Director | Form 4 sale | 13,777 | $733k | 23.1% | Plan not stated | SEC |
| Feb 17, 2021 | KKR Genetic Disorder L.P. | 10% owner | Form 4 sale | 3.5M | $209M | 10.0% | Plan not stated | SEC |
| Dec 28, 2020 | Turtle Cameron | Officer | Form 4 sale | 19,500 | $1.4M | 60.8% | Unusual | SEC |
| Dec 21, 2020 | Scheller Richard H | Officer, Director | Form 4 sale | 60,401 | $3.9M | 56.8% | Unusual | SEC |
| Dec 18, 2020 | Scheller Richard H | Officer, Director | Form 4 sale | 30,000 | $2M | 22.0% | Plan not stated | SEC |
| Dec 15, 2020 | Scheller Richard H | Officer, Director | Form 4 sale | 31,443 | $1.9M | 18.7% | Plan not stated | SEC |
| Dec 1, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 10,000 | $515k | 3.5% | Plan not stated | SEC |
| Nov 25, 2020 | Turtle Cameron | Officer | Form 4 sale | 5,000 | $235k | 28.5% | Unusual | SEC |
| Nov 16, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 10,000 | $450k | 3.6% | Plan not stated | SEC |
| Nov 13, 2020 | Mccormick Frank | Chairman of Oncology | Form 4 sale | 100,000 | $4.3M | 7.7% | Plan not stated | SEC |
| Nov 5, 2020 | Turtle Cameron | Officer | Form 4 sale | 2,500 | $105k | 16.6% | Plan not stated | SEC |
| Nov 2, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 10,000 | $384k | 3.6% | Plan not stated | SEC |
| Oct 16, 2020 | Homcy Charles J | Chairman of Pharmaceuticals | Form 4 sale | 10,256 | $420k | 0.8% | Plan not stated | SEC |
| Oct 1, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 10,000 | $388k | 3.6% | Plan not stated | SEC |
| Sep 30, 2020 | Turtle Cameron | Officer | Form 4 sale | 14,500 | $546k | 53.6% | Unusual | SEC |
| Sep 30, 2020 | Homcy Charles J | Chairman of Pharmaceuticals | Form 4 sale | 10,000 | $380k | 0.8% | Plan not stated | SEC |
| Sep 29, 2020 | Homcy Charles J | Chairman of Pharmaceuticals | Form 4 sale | 99,257 | $3.7M | 7.6% | Plan not stated | SEC |
| Sep 18, 2020 | Turtle Cameron | Officer | Form 4 sale | 2,500 | $105k | 16.6% | Plan not stated | SEC |
| Sep 18, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 10,000 | $400k | 3.6% | Plan not stated | SEC |
| Sep 16, 2020 | Scheller Richard H | Officer, Director | Form 4 sale | 25,000 | $938k | 15.3% | Plan not stated | SEC |
| Sep 15, 2020 | Turtle Cameron | Officer | Form 4 sale | 2,500 | $93k | 16.6% | Plan not stated | SEC |
| Sep 11, 2020 | Turtle Cameron | Officer | Form 4 sale | 2,000 | $70k | 13.7% | Plan not stated | SEC |
| Sep 1, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 10,000 | $287k | 3.6% | Plan not stated | SEC |
| Aug 4, 2020 | Stephenson Brian C | Officer | Form 4 sale | 7,200 | $196k | 2.4% | Plan not stated | SEC |
| Aug 4, 2020 | Kumar Neil | CEO and President | Form 4 sale | 80,000 | $2.2M | 3.7% | Plan not stated | SEC |
| Aug 3, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 10,000 | $274k | 3.7% | Plan not stated | SEC |
| Jul 2, 2020 | Kumar Neil | CEO and President | Form 4 sale | 143,470 | $4.4M | 6.2% | Plan not stated | SEC |
| Jul 1, 2020 | Stephenson Brian C | Officer | Form 4 sale | 10,800 | $334k | 3.5% | Plan not stated | SEC |
| Jul 1, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 10,000 | $310k | 3.7% | Unusual | SEC |
| Jun 30, 2020 | Turtle Cameron | Officer | Form 4 sale | 10,000 | $327k | 50.4% | Unusual | SEC |
| Jun 8, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 606 | $18k | 0.2% | Plan not stated | SEC |
| Jun 8, 2020 | Kumar Neil | CEO and President | Form 4 sale | 10,600 | $318k | 0.5% | Plan not stated | SEC |
| Jun 8, 2020 | Stephenson Brian C | Officer | Form 4 sale | 2,000 | $60k | 0.7% | Plan not stated | SEC |
| Jun 3, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 784 | $24k | 0.3% | Plan not stated | SEC |
| Jun 3, 2020 | Stephenson Brian C | Officer | Form 4 sale | 1,600 | $48k | 0.5% | Plan not stated | SEC |
| Jun 3, 2020 | Kumar Neil | CEO and President | Form 4 sale | 5,930 | $178k | 0.3% | Plan not stated | SEC |
| Jun 1, 2020 | Kumar Neil | CEO and President | Form 4 sale | 80,000 | $2.3M | 3.3% | Plan not stated | SEC |
| Jun 1, 2020 | Stephenson Brian C | Officer | Form 4 sale | 7,200 | $211k | 2.3% | Plan not stated | SEC |
| Jun 1, 2020 | Henderson Michael Thomas | Chief Business Officer | Form 4 sale | 2,585 | $76k | 1.0% | Plan not stated | SEC |
| May 28, 2020 | KKR Genetic Disorder L.P. | 10% owner | Form 4 sale | 2.4M | $79.8M | 6.5% | Plan not stated | SEC |
| May 5, 2020 | Henderson Michael Thomas | Officer | Form 4 sale | 1,460 | $44k | 0.9% | Plan not stated | SEC |
| May 5, 2020 | Stephenson Brian C | Officer | Form 4 sale | 5,706 | $174k | 1.8% | Plan not stated | SEC |
| May 5, 2020 | Kumar Neil | CEO and President | Form 4 sale | 79,600 | $2.5M | 3.2% | Plan not stated | SEC |
| May 4, 2020 | Kumar Neil | CEO and President | Form 4 sale | 80,400 | $2.4M | 3.1% | Plan not stated | SEC |
| May 4, 2020 | Stephenson Brian C | Officer | Form 4 sale | 8,694 | $255k | 2.6% | Plan not stated | SEC |
| May 4, 2020 | Henderson Michael Thomas | Officer | Form 4 sale | 3,905 | $115k | 2.3% | Plan not stated | SEC |
| Apr 27, 2020 | Turtle Cameron | Officer | Form 4 sale | 2,000 | $64k | 16.9% | Plan not stated | SEC |
| Apr 8, 2020 | Turtle Cameron | Officer | Form 4 sale | 8,000 | $216k | 44.9% | Unusual | SEC |
| Apr 7, 2020 | Kumar Neil | CEO and President | Form 4 sale | 1,805 | $46k | 0.1% | Plan not stated | SEC |
| Apr 3, 2020 | Kumar Neil | CEO and President | Form 4 sale | 300 | $8k | 0.0% | Plan not stated | SEC |
| Apr 2, 2020 | Kumar Neil | CEO and President | Form 4 sale | 77,895 | $2M | 2.9% | Plan not stated | SEC |
| Apr 1, 2020 | Henderson Michael Thomas | Officer | Form 4 sale | 2,585 | $70k | 1.5% | Plan not stated | SEC |
| Apr 1, 2020 | Stephenson Brian C | Officer | Form 4 sale | 7,200 | $192k | 2.1% | Plan not stated | SEC |
| Mar 3, 2020 | Kumar Neil | CEO and President | Form 4 sale | 120,000 | $3.9M | 4.3% | Plan not stated | SEC |
| Mar 2, 2020 | Stephenson Brian C | See Remark | Form 4 sale | 10,800 | $349k | 3.1% | Plan not stated | SEC |
| Mar 2, 2020 | Henderson Michael Thomas | Officer | Form 4 sale | 3,975 | $129k | 2.3% | Plan not stated | SEC |
| Feb 11, 2020 | Turtle Cameron | Officer | Form 4 sale | 2,000 | $75k | 16.9% | Plan not stated | SEC |
| Feb 10, 2020 | Homcy Charles J | Chairman of Pharmaceuticals | Form 4 sale | 20,000 | $720k | 1.5% | Plan not stated | SEC |
| Feb 5, 2020 | Kumar Neil | CEO and President | Form 4 sale | 30,893 | $1.1M | 1.1% | Plan not stated | SEC |
| Feb 4, 2020 | Kumar Neil | Officer, Director | Form 4 sale | 89,107 | $3.1M | 3.1% | Plan not stated | SEC |
| Feb 4, 2020 | Stephenson Brian C | Officer | Form 4 sale | 10,800 | $375k | 3.0% | Plan not stated | SEC |
| Feb 3, 2020 | Henderson Michael Thomas | Officer | Form 4 sale | 3,975 | $139k | 2.2% | Plan not stated | SEC |
| Jan 14, 2020 | Homcy Charles J | Chairman of Pharmaceuticals | Form 4 sale | 10,000 | $350k | 0.7% | Plan not stated | SEC |
| Jan 8, 2020 | Turtle Cameron | Officer | Form 4 sale | 12,807 | $440k | 56.6% | Unusual | SEC |
| Jan 3, 2020 | Henderson Michael Thomas | Officer | Form 4 sale | 3,975 | $132k | 2.2% | Plan not stated | SEC |
| Jan 3, 2020 | Kumar Neil | Officer, Director | Form 4 sale | 120,000 | $3.9M | 4.0% | Plan not stated | SEC |
| Jan 3, 2020 | Stephenson Brian C | Officer | Form 4 sale | 10,800 | $356k | 2.9% | Plan not stated | SEC |
| Dec 30, 2019 | Mccormick Frank | Chairman of Oncology | Form 4 sale | 100,000 | $3.8M | 7.3% | Plan not stated | SEC |